Contraception News and Research

RSS
LC-MS/MS test for progesterone outperforms traditional immunoassays

LC-MS/MS test for progesterone outperforms traditional immunoassays

Oral contraceptives may reduce risk of ACL tears in women

Oral contraceptives may reduce risk of ACL tears in women

Will ties to a Catholic hospital system tie doctors’ hands?

Will ties to a Catholic hospital system tie doctors’ hands?

Podcast: KHN’s ‘What the Health?’ The abortion wars rage on

Podcast: KHN’s ‘What the Health?’ The abortion wars rage on

Study explores factors that impact fertility preservation decisions in transgender youth

Study explores factors that impact fertility preservation decisions in transgender youth

FDA approves new treatment for adults with metastatic bladder cancer

FDA approves new treatment for adults with metastatic bladder cancer

Unisex, hormone-free contraceptive pill on the horizon

Unisex, hormone-free contraceptive pill on the horizon

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

New guidance on use of valproate in women, girls of child bearing age with epilepsy published

New guidance on use of valproate in women, girls of child bearing age with epilepsy published

Early menopause raises bladder cancer risk for smokers

Early menopause raises bladder cancer risk for smokers

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Contraceptive jewelry may be new approach to family planning for women

Contraceptive jewelry may be new approach to family planning for women

Male contraceptive pill crosses the human clinical trial hurdle

Male contraceptive pill crosses the human clinical trial hurdle

FDA approves new drug to treat adults with relapsing forms of MS

FDA approves new drug to treat adults with relapsing forms of MS

Male contraceptive pill shown to be safe and tolerable in phase I trial

Male contraceptive pill shown to be safe and tolerable in phase I trial

Podcast: KHN’s ‘What the Health?’ The karma of cutting Medicare

Podcast: KHN’s ‘What the Health?’ The karma of cutting Medicare

Global study highlights growing inequality in adolescent health

Global study highlights growing inequality in adolescent health

Podcast: KHN’s ‘What the Health?’ ‘Medicare-for-all’ debate: Who’s going to pay

Podcast: KHN’s ‘What the Health?’ ‘Medicare-for-all’ debate: Who’s going to pay

Despite 1991 ruling, foes of new family planning rules see law on their side

Despite 1991 ruling, foes of new family planning rules see law on their side

Study shows use of 'the abortion pill' bounced back in Texas after FDA label change

Study shows use of 'the abortion pill' bounced back in Texas after FDA label change